Display Settings:

Format

Send to:

Choose Destination
Endocrine. 2003 Jun;21(1):67-75.

Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.

Author information

  • 1Department of Anatomy, Northeastern Ohio Universities College of Medicine, Rootstown 44272, USA. ded@neoucom.edu

Abstract

In this review, we relate both laboratory and clinical evidence associated with the capacity for estrogen to function as a modulator of nigrostriatal dopaminergic pathology. To accomplish this goal, we have divided this review into three parts. In Part 1, we provide a brief historical perspective of studies that have laid the groundwork for demonstrating the existence of hormonal- nigrostriatal interactions. In Part 2, we focus specifically on laboratory data that show the ability and conditions by which estrogen may function as a neuroprotectant of the nigrostriatal dopaminergic system. Finally, in Part 3, we review the clinical literature related to this issue as a means for consideration of estrogen as a modulator, neuroprotectant, and therapy for Parkinson disease.

PMID:
12777705
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk